Richard W. Paul & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1K Buy
295
+183
+163% +$14.8K 0.01% 204
2026
Q1
$9.71K Buy
+112
New +$10.7K ﹤0.01% 222
2024
Q1
Sell
-128
Closed -$10.5K 526
2023
Q4
$10.5K Sell
128
-29
-18% -$2.21K ﹤0.01% 299
2023
Q3
$12.3K Buy
157
+11
+8% +$921 0.01% 280
2023
Q2
$12.9K Sell
146
-3
-2% -$258 0.01% 297
2023
Q1
$12K Buy
149
+10
+7% +$815 0.01% 305
2022
Q4
$10.8K Buy
+139
New +$11.3K 0.01% 318

Other funds holding MDT

Richard W. Paul & Associates's MDT Position: Q2 2026 in Review

Richard W. Paul & Associates increased its Medtronic (MDT) stake by 163% in Q2 2026, buying an estimated $14.8K and bringing the position to 295 shares worth $23.1K. The position accounts for 0.01% of the portfolio, ranked #204.

Richard W. Paul & Associates first reported a position in MDT in Q4 2022 and has held it in 7 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Richard W. Paul & Associates held 295 shares of Medtronic worth $23.1K as of Q2 2026.
  • Richard W. Paul & Associates bought 183 Medtronic shares in Q2 2026, an estimated $14.8K.
  • Medtronic made up 0.01% of Richard W. Paul & Associates's portfolio in Q2 2026, its #204 holding.
  • Richard W. Paul & Associates first reported a position in Medtronic in Q4 2022 and has held it in 7 quarters since.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.